Cytodyn Inc (CYDY)

[misiu143]

QUOTE..
----------------------------------------------------------------

Lero efficacy in various cancers may vary widely due to many other factors such as varied expression of CCR5 on tumors , immune cells such as macrophages etc ;

----------------------------------------------------------------

Our 2 first patients as per Dr NP during yesterday presentation , CCR5 on tumors cells were 0 ...and they both had high CCR5 on macrophages surrounding tumors , so CCR5 doesn't have to be always on tumors cells itself...

Every patient admitted for this treatment has biopsy evaluated for presence of CCR5 , so there is a good chance that most of patients will improve , with different degree I am sure , maybe depending how high CCR5 expression is.

Different studies so far showing that the most deadly cancers have the highest CCR5 expression..
All the MM, pancreatic cancer , colon cancer , some brain cancers , lung stomach , esophagus , breast cancers, throat , and others ..

We have 50-60 patient with different cancers , now waiting for treatment ,
Soon they should start , and we may see results few weeks later..

Look that this is a very good treatment for many , and so far without one serious side effect..
In mice , metastasis were stopped for 19 weeks now , what is 19 years in humans , if study will duplicate , but so far they are ..

Hard to compete for many cancers , if our results will be confirm by study ...

GLTU.


IMO only..